Rigel Pharmaceuticals
RIGL
#6623
Rank
C$1.15 B
Marketcap
C$61.37
Share price
-1.85%
Change (1 day)
2.75%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): C$24.29

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$25.27. In 2025 the company made an earnings per share (EPS) of C$28.94 an increase over its 2024 EPS that were of C$1.42.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$24.29-16.07%
2025C$28.941944.44%
2024C$1.42
2022C-$4.86240%
2021C-$1.43-37.5%
2020C-$2.29-60%
2019C-$5.72-11.11%
2018C-$6.43-26.23%
2017C-$8.72-17.57%
2016C-$10.5825.42%
2015C-$8.44-42.72%
2014C-$14.73
2012C-$19.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$24.85-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.18-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
C-$0.54-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
C-$2.70-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA